CAPRELSA
Identification of Caprelsa
Please sign up for a free trial to see the description of this product.
Examples of the descriptions of OTHER drugs:
Lipitor 10 mg
Apo-Irbesartan 150 mg
Crestor 20 mg
Google image searchProduct monograph
Active ingredient
vandetanib, 100 MG
DIN: 02378582
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SANOFI-AVENTIS CANADA INC
Date: 05-APR-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX04 — VANDETANIB (ATC/DDD)
Reference brand drug: Caprelsa
External Links for Caprelsa
Search on Google
Sanofi-Aventis Canada Inc
Go to Sanofi-Aventis website to see drug product details. Sometimes you can find caprelsa photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.